Tag: Injectable
MedinCell – Partner Teva provides 2024 sales forecast for UZEDY™ and provides update on long-acting injectable olanzapine treatment candidate – 01/31/2024 at 10:00 p.m.
· UZEDY revenue forecast for Teva in 2024: ~$80 million · Ongoing phase 3 of Olanzapine LAI: l675 patients (recruitment completed), 62% of 3,600 planned injections completed, no PDSS (post-injection…
MedinCell – Partner Teva announces the end of patient recruitment in the phase 3 clinical study of mdc-TJK, long-acting injectable treatment of olanzapine – 01/09/2024 at 7:20 p.m.
Teva Pharmaceuticals Industries Ltd., announced at the JP Morgan Healthcare Conference that it has successfully completed recruitment in Europe and the United States of the planned 640 participants in the…
Lilly and co: Arrival of injectable Zepbound on the US market
Read also (CercleFinance.com) – Eli Lilly announced today that Zepbound (tirzepatide) injection is now available. As a reminder, Zepbound is indicated for obese adults (i.e. whose BMI is equal to…
MedinCell: start of the Phase 3 study for the second long-acting injectable antipsychotic
Through Olivier Cheilan Published on 01/24/2023 at 6:20 p.m. (Boursier.com) —…
feu vert pour le premier vaccin injectable chez tous les nourrissons de moins d’un an
NEWSLETTERS you fun, the news, the bonus plan… what else ? Alors qu’une épidémie de bronchiolite a fait de nombreux petits malades l’hiver dernier, l’Agence européenne du médicament a donné…
Launch of a phase 3 study for the second long-acting injectable antipsychotic using MedinCell technology – 08/29/2022 at 18:00
Teva Pharmaceuticals has informed MedinCell of its decision to initiate the Phase 3 clinical trial for mdc-TJK. MedinCell will immediately receive a $3 million payment from Teva Pharmaceuticals for reaching…
Injectable HIV treatment reimbursed in France
Cabotegravir (here the computerized molecular structure) is combined with rilpivirine for a bimonthly injection. TIM EVANS / SCIENCE PHOTO LIBRARY Since the development in 1996 of the first triple therapies,…